Navigation Links
European Commission Designates MST-188 As An Orphan Medicinal Product
Date:3/25/2013

may provide significant benefit to those affected by that condition.  

Authorized orphan medicines benefit from 10 years of marketing exclusivity in the European Union (EU), meaning that in the 10 years after marketing authorization similar products with a comparable indication cannot be placed on the market, except in limited circumstances.  This period of marketing exclusivity is extended by two years for medicines that also have complied with an agreed pediatric investigation plan.  The EMA also provides a form of scientific advice specifically for orphan medicines, called protocol assistance.  This allows sponsors to receive answers to questions on the types of studies needed to demonstrate the medicine's quality and benefits and risks.  In addition, all designated orphan medicines are assessed for marketing authorization centrally in the EU. This allows companies to make a single application to the EMA, resulting in a single opinion and a single decision from the EC, valid in all EU member states. 

About Mast Therapeutics

Mast Therapeutics, Inc. is a publicly traded biopharmaceutical company headquartered in San Diego, CA.  The Company is leveraging the MAST (Molecular Adhesion and Sealant Technology) platform, derived from over two decades of clinical, nonclinical and manufacturing experience with purified and non-purified poloxamers, to develop MST-188, its lead product candidate, for serious or life-threatening diseases with significant unmet needs.  MST-188 is a cytoprotective, hemorheologic, anti-inflammatory and anti-thrombotic agent that has potential utility in diseases or conditions characterized by microcirculatory insufficiency (endothelial dysfunction and/or impaired blood flow). 

The Company is recruiting subjects in EPIC, a pivotal phase 3 study of MST-188 in sickle cell disease.  The Company plans to initiate a phase 2 clinical study of M
'/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
2. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
3. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
4. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
5. Mylan Launches Generic Lipitor® in Five European Countries
6. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
7. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
8. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
9. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
10. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , Aug. 3, 2015 Immune Pharmaceuticals, Inc. ... Dr. Daniel Teper , will present live at ... 6, 2015 TIME:   11:30AM EDT LINK:    http://tinyurl.com/aug6-pre-imnp ... interactive online event where investors are invited to ask ... presentation hall as well as the association,s "virtual trade ...
(Date:8/3/2015)... SAN DIEGO , Aug. 3, 2015  Sorrento ... that it has entered into an exclusive licensing agreement ... or biobetter antibodies from Mabtech Limited, a holding company ... China . Under the ... these 4 monoclonal antibodies (mAbs) for the North American, ...
(Date:7/31/2015)... , July 31, 2015  In today,s ever-changing marketplace, ... are increasingly mobile, increasingly connected, and increasingly impatient with ... of customer interaction channels and tools is driving call ... media. According to research by benchmarking ... counter (OTC) segment in a call center study realize ...
Breaking Medicine Technology:Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 4Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2
... , ABBOTT PARK, Ill., July 28 ... Food and Drug Administration (FDA) approval for two new ... SIMCOR dosage strengths combine 40 mg of simvastatin – ... either 500 mg or 1,000 mg of niacin extended-release. ...
... In FDLI,s latest monograph, Selling Pharmaceuticals and Biologics to ... , Joy Sturm , Allison Pugsley ... Hogan Lovells US LLP detail how pharmaceutical and ... price calculation requirements. The 73-page monograph (Volume 1, #5) succinctly ...
Cached Medicine Technology:Abbott's SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths 2Abbott's SIMCOR ® ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths 3New FDLI Monograph Provides Expert Guidance on Selling Pharmaceuticals, Biologics to Federal Government 2
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... Health notes that while an overwhelming number of Hispanics believe people can ... The overwhelming 70 percent of participants queried said making diet changes was important. ...
(Date:8/3/2015)... ... 2015 , ... Dental practice in Los Angeles , Sunset Plaza Dental, ... that general health emergencies, such as broken arms or a heart attack, should be ... turn to during a dental emergency. This is important, because dental trauma is extremely ...
(Date:8/3/2015)... ... , ... The art of preparing and cooking food comes naturally to some. ... age, Nasreen Zereshki was extremely eager to cook Persian cuisine. Now that she is ... Persian Kitchen with the world. , Since Americans tend to be undereducated about Persian ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sensato and ... “Designing Secure Healthcare Systems” This three-day, highly interactive and immersive workshop, has ... with access to the tactics, techniques and practices required to design and develop ...
(Date:8/3/2015)... Los Angeles, CA (PRWEB) , ... August 03, 2015 , ... ... trend has emerged among U.S. emergency rooms in recent years, according to the American ... 2012, the number of dental emergency visits went from 1.1 million in a single ...
Breaking Medicine News(10 mins):Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3
... without hepatocellular carcinoma (HCC) derive a greater survival benefit ... for a deceased donor liver transplant (DDLT). The study ... journal published by Wiley-Blackwell on behalf of the American ... survival benefit from LDLT remains significant across the range ...
... , TUESDAY, Sept. 27 (HealthDay News) -- ... lethal prostate cancers have been identified by scientists who ... of cancers. The team also identified several instances ... that can give the cancers resistance to therapies commonly ...
... negative effects that premature birth can have on the lungs ... as those born extremely prematurely but may be reversed in ... research will be presented at the European Respiratory Society Annual ... lasts 40 weeks, which allows enough time for the infant ...
... For all long-term care residents, pressure reduction foam mattresses ... mattresses, with average savings of $115 per resident, the ... cost-effective 94% of the time compared to soap and ... The clinical benefits of foam cleansers for bedsores, or ...
... , MONDAY, Sept. 26 (HealthDay News) -- Older women ... within a year because of the fracture, not an underlying health ... that it is the hip fracture, and not just poor health, ... author Dr. Teresa Hillier, a senior investigator at the Kaiser Permanente ...
... Doctors and other medical professionals occasionally joke about their ... but some joking between medical professionals is not only ... in the Hastings Center Report . The ... and comedy: she is an assistant professor in the ...
Cached Medicine News:Health News:Living donor liver transplantation improves survival over deceased donor transplants 2Health News:Lung function of moderately premature babies is reduced at 8-9 years but may improve with age 2Health News:Prevention of bedsores in long-term care homes cost-effective, study shows 2Health News:Hip Fracture May Raise a Woman's Risk of Earlier Death 2Health News:Is gallows humor in medicine wrong? 2
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... Captia™ Legionella pneumophila IgG/IgM Enzyme-Linked ... for the qualitative detection of ... to Legionella pneumophila (Legionella) serogroups ... with clinical suspicion of Legionella ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: